혈액 및 혈액 성분 시장 규모, 점유율, 성장 분석 : 제품 유형별, 채취 방법별, 용도별, 최종사용자별, 보존 방법별, 유통 채널별, 지역별 - 업계 예측(2026-2033년)

Global Blood And Blood Components Market size was valued at USD 13.1 Billion in 2024 and is poised to grow from USD 13.55 Billion in 2025 to USD 17.7 Billion by 2033, growing at a CAGR of 3.4% during the forecast period (2026-2033).

The global blood and blood components market encompasses the production and distribution of vital products such as whole blood, red cells, plasma, and platelets, along with derived therapeutics. This market is driven by the increasing prevalence of hemoglobinopathies and oncology treatments, which heighten demand across various regions, including North America, Europe, and Asia. The rising adoption of advanced apheresis technologies further enhances market dynamics by allowing efficient plasma collection and reducing reliance on donor pools, thereby facilitating increased production of crucial biologics. Additionally, AI is revolutionizing blood component manufacturing by automating quality checks and optimizing inventory management. Enhanced safety standards and operational efficiencies are realized through machine learning, fostering a reliable supply chain and encouraging investment in the sector, ultimately propelling market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Blood And Blood Components market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Blood And Blood Components Market Segments Analysis

Global blood and blood components market is segmented by by product type, by collection type, by application, by end user, by storage type, by distribution channel and region. Based on by product type, the market is segmented into Whole Blood, Blood Components and Blood Derivatives. Based on by collection type, the market is segmented into Voluntary Blood Donation, Autologous Blood Collection and Apheresis Collection. Based on by application, the market is segmented into Trauma & Emergency Care, Surgeries, Cancer Treatment, Hematological Disorders, Cardiovascular Diseases, Organ Transplantation and Others. Based on by end user, the market is segmented into Hospitals, Blood Banks, Ambulatory Surgical Centers, Specialty Clinics and Others. Based on by storage type, the market is segmented into Refrigerated Blood Storage, Frozen Blood Storage and Room Temperature Storage. Based on by distribution channel, the market is segmented into Hospital-based Distribution, Regional Blood Centers and National Blood Services. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Blood And Blood Components Market

The demand for blood and blood components is significantly driven by the growing incidence of complex surgeries and trauma cases, which necessitate safe and accessible blood products. As hospitals strive to enhance their transfusion services, they are investing in advanced inventory management systems, leading to increased demand throughout the supply chain. This heightened necessity urges manufacturers to expand their production capabilities in order to satisfy clinical needs. Additionally, the development of healthcare infrastructure in emerging markets fosters greater access to surgical interventions, further increasing demand. Clinicians are also leaning towards component-specific therapies that improve patient outcomes, contributing to the overall growth of the market.

Restraints in the Global Blood And Blood Components Market

The Global Blood and Blood Components market faces several significant constraints that hinder its growth. Stringent approval processes and comprehensive documentation requirements established by health authorities place notable financial and time pressures on manufacturers and blood collection agencies, making it challenging for new products to enter the market quickly and for existing operations to expand. Additionally, the necessity to comply with continuously changing safety regulations often leads to frequent upgrades of facilities and ongoing staff training, contributing to delays in product launches and increased operational costs. Furthermore, varying regulations across regions complicate international distribution, necessitating customized compliance approaches that further tax resources.

Market Trends of the Global Blood And Blood Components Market

The Global Blood and Blood Components market is witnessing a significant shift towards advanced pathogen inactivation technologies, which are revolutionizing the way blood products are treated and stored. As healthcare facilities focus on enhancing transfusion safety and minimizing the risks associated with infectious agents, there is an increasing adoption of next-generation solutions that can effectively neutralize viruses, bacteria, and parasites while preserving the functionality of blood products. This trend not only extends storage capabilities, making it particularly beneficial for remote and resource-limited settings, but also fosters stronger collaborations between manufacturers and healthcare providers, ultimately influencing procurement strategies throughout the industry.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Blood and Blood Components Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Whole Blood
• Blood Components
  • Red Blood Cells
  • Platelets
  • Plasma
  • Cryoprecipitate
  • Others
• Blood Derivatives
  • Immunoglobulins
  • Albumin
  • Coagulation Factors
  • Others

Global Blood and Blood Components Market Size by Collection Type & CAGR (2026-2033)

• Market Overview
• Voluntary Blood Donation
• Autologous Blood Collection
• Apheresis Collection

Global Blood and Blood Components Market Size by Application & CAGR (2026-2033)

• Market Overview
• Trauma & Emergency Care
• Surgeries
• Cancer Treatment
• Hematological Disorders
• Cardiovascular Diseases
• Organ Transplantation
• Others

Global Blood and Blood Components Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Blood Banks
• Ambulatory Surgical Centers
• Specialty Clinics
• Others

Global Blood and Blood Components Market Size by Storage Type & CAGR (2026-2033)

• Market Overview
• Refrigerated Blood Storage
• Frozen Blood Storage
• Room Temperature Storage

Global Blood and Blood Components Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Hospital-based Distribution
• Regional Blood Centers
• National Blood Services

Global Blood and Blood Components Market Size & CAGR (2026-2033)

• North America (By Product Type, By Collection Type, By Application, By End User, By Storage Type, By Distribution Channel)
  • US
  • Canada
• Europe (By Product Type, By Collection Type, By Application, By End User, By Storage Type, By Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (By Product Type, By Collection Type, By Application, By End User, By Storage Type, By Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (By Product Type, By Collection Type, By Application, By End User, By Storage Type, By Distribution Channel)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (By Product Type, By Collection Type, By Application, By End User, By Storage Type, By Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Grifols
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CSL Behring
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takeda Pharmaceutical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Octapharma
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kedrion Biopharma
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Baxter International
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius Kabi
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio Products Laboratory
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LFB Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• China Biologic Products
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Japan Blood Products Organization
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanquin
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kawasumi Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Macopharma
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Haemonetics Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Immucor
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cerus Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ortho Clinical Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations